Loading
Life sciences · Journal article
Journal of Affective Disorders · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Introduction. Major depressive disorder (MDD) has been linked to increased incidence of cardiometabolic disease (CMD). Depressive symptom profiles associated with inflammation (atypical energy-related symptoms (AES), anhedonia) may carry specific cardiometabolic risk. We investigated whether MDD, AES and anhedonia are associated with higher CMD incidence compared to typical depressive symptoms and control participants.Methods. Data were from the Netherlands Study of Depression and Anxiety (NESDA), including participants with lifetime MDD and non-depressed controls, without baseline CMD (N = 1858). CMD incidence was established over 15-year follow-up using self-report, medication use, and glucose. AES, anhedonia, typical symptoms, and depression severity were derived from the Inventory of Depressive Symptomatology Self-Report. Cox proportional hazard models were adjusted for sociodemographic and lifestyle factors.Results. CMD incidence rate was 21.3/1000 person years. MDD was associated with increased CMD incidence compared to controls (HR = 1.65, 95%CI: 1.30-2.11). In continuous analyses, only AES and depression severity were significantly associated with CMD incidence, though effect sizes were comparable across symptom profiles. When divided into severity tertiles and compared to controls, associations were largely similar across profiles, with no clear dose-response pattern. All profiles were associated with cardiovascular disease incidence, but only AES was associated with diabetes incidence.Discussion. MDD is associated with CMD incidence over 15 years. Depressive symptom profiles did not show differential associations with CMD incidence. Effect sizes across profiles were comparable, suggesting a general rather than symptom-specific depression burden on cardiometabolic health risk. Continued monitoring of cardiometabolic risk factors is warranted for people with a history of depression.